Secuelas de salud a medio plazo en brasileños recuperados de COVID-19 según gravedad

• Alba Camacho-Cardenosa ^[1] ; Javier Brazo-Sayavera ^[2] ; Marta Camacho Cardeñosa ^[3] ; Gabriel Peinado-Costa ^[4] ; Ester Wiggers ^[7] ; Elisangela Aparecida da Silva-Lizzi ^[5] ; Pedro Vieira Da Silva-Neto ^[6] ; João Pedro Rodrigues-Campos Renon ^[8] ; Carlos Arterio Sorgi ^[9] ; Átila Alexandre Trapé ^[4]
  1. [1] Universidad de Granada

     Universidad de Granada

     Granada, España

     
  2. [2] Universidad Pablo de Olavide

     Universidad Pablo de Olavide

     Sevilla, España

     
  3. [3] Instituto Maimónides de Investigación Biomédica de Córdoba

     Instituto Maimónides de Investigación Biomédica de Córdoba

     Cordoba, España

     
  4. [4] Universidade de São Paulo

     Universidade de São Paulo

     Brasil

     
  5. [5] Federal University of Technology

     Federal University of Technology

     Nigeria

     
  6. [6] Universidade Federal do Amazonas

     Universidade Federal do Amazonas

     Brasil

     
  7. [7] Ribeirao Preto Medical School, USP
  8. [8] Faculty of Pharmaceutical Sciences of Ribeirao Preto (FCFRP), USP
  9. [9] Faculty of Philosophy, Sciences and Letters of Ribeirao Preto (FFCLRP), USP

  Mostrar afiliaciones +
• Localización: Revista andaluza de medicina del deporte, ISSN 1888-7546, Vol. 16, Nº. 3-4, 2023
• Idioma: español
• Enlaces
  • Texto completo
• Resumen

  • The aims were to identify the symptoms and comorbidities predictive for severe illness and analyse the mild-term health sequelae in Brazilian recovered from COVID-19. Eighty-four participants were divided into mild (n = 16), moderate (n = 51), severe (n = 9) or critical (n = 8) gravity. A standardized assessment included: anamnesis to identify the symptoms and comorbidities; and cardiorespiratory system, body composition, haematological and immunological indicators, and physical fitness to analyze the mild-term health sequelae. Participants with higher gravity presented fever, fatigue and dyspnoea. Diabetes (p = 0.003), hypertension (p < 0.001) and metabolic syndrome (p = 0.010) were the comorbidities significantly associated for severe or critical illness. People with critical gravity reported a significant higher waist/hip ratio and level of visceral fat compared with mild and moderate severity. Severe and critical participants reported worst results in agility and balance test compared with mild (p = 0.015; p = < 0.001, respectively) and moderate (p = 0.014; p = < 0.001, respectively) gravity. Fever, fatigue and dyspnoea; and diabetes, hypertension and metabolic syndrome were the symptoms and comorbidities associated with higher gravity. Mild-term, altered values of body composition, physical functioning, enhanced glucose, reticulocytes, and lymphocytes levels were reported.